Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)

SHA:603983 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,695	2,032	1,077	1,073	806.1	1,670
Short-Term Investments	-	44.08	279.64	333.41	115.15	-
Trading Asset Securities	390.11	395.7	767.98	437.78	738.09	820.58
Cash & Short-Term Investments	2,085	2,472	2,124	1,844	1,659	2,490
Cash Growth	4.03%	16.36%	15.19%	11.14%	-33.37%	-14.05%
Accounts Receivable	58.48	46.43	31.5	73.93	62.85	5.22
Other Receivables	12.03	11.57	14.64	7.43	7.42	3.56
Receivables	70.51	58	46.14	81.36	70.26	8.78
Inventory	243.01	219.66	171.73	151.7	138.43	138.3
Prepaid Expenses	-	-	-	-	4.9	1.7
Other Current Assets	242.82	204.83	187.75	159.99	102.88	42.45
Total Current Assets	2,641	2,954	2,530	2,237	1,976	2,682
Property, Plant & Equipment	1,093	1,082	769.91	520.59	384.14	246.02
Long-Term Investments	180.66	165.66	63.61	73.87	75.12	49.89
Other Intangible Assets	694.68	699.16	719.58	748.63	764.56	18.63
Long-Term Deferred Tax Assets	85.61	91.85	59.1	42.16	21.67	30.59
Long-Term Deferred Charges	16.62	1.74	3.17	2.58	9.98	21.25
Other Long-Term Assets	67.98	67.96	308.41	469.07	530.38	747
Total Assets	4,780	5,063	4,454	4,094	3,762	3,795
Accounts Payable	285.21	253.14	178.15	152.94	154.46	203.13
Accrued Expenses	15.59	167.8	156.78	156.8	104.95	107.22
Short-Term Debt	510	790.1	100.07	100	-	106.7
Current Portion of Long-Term Debt	1	-	148.1	2.1	-	-
Current Portion of Leases	-	2.36	4.05	8.65	4.79	-
Current Income Taxes Payable	51.78	32.67	15.45	27.98	24.76	36.82
Current Unearned Revenue	189.81	195.12	240.4	94.53	144.57	227.78
Other Current Liabilities	127.49	155.34	167.19	125.47	143.02	104.98
Total Current Liabilities	1,181	1,597	1,010	668.47	576.55	786.64
Long-Term Debt	-	-	-	148	-	-
Long-Term Leases	0.51	1.5	3.25	11.68	14.68	-
Long-Term Unearned Revenue	5.18	5.39	6.16	5.56	9.51	5.83
Long-Term Deferred Tax Liabilities	12.09	12.26	15.23	7.85	2.45	1.97
Other Long-Term Liabilities	0.36	0.36	0.36	-	-	-
Total Liabilities	1,199	1,616	1,035	841.56	603.19	794.44
Common Stock	401	401	401	401.44	401.82	401
Additional Paid-In Capital	761	761	760.45	774.49	780.12	754.29
Retained Earnings	2,355	2,220	2,187	2,028	1,930	1,823
Treasury Stock	-	-	-	-14.47	-26.66	-
Comprehensive Income & Other	-1.77	-1.71	-1.58	-1.49	-1.28	-0.29
Total Common Equity	3,515	3,380	3,347	3,188	3,084	2,978
Minority Interest	65.39	66.1	71.42	64.51	74.36	22.9
Shareholders' Equity	3,581	3,447	3,419	3,253	3,158	3,001
Total Liabilities & Equity	4,780	5,063	4,454	4,094	3,762	3,795
Total Debt	511.5	793.97	255.48	270.44	19.47	106.7
Net Cash (Debt)	1,573	1,678	1,869	1,574	1,640	2,384
Net Cash Growth	-14.85%	-10.22%	18.75%	-4.03%	-31.21%	-17.73%
Net Cash Per Share	3.91	4.17	4.68	3.89	4.10	5.95
Filing Date Shares Outstanding	401	401	401	401.44	401.82	401
Total Common Shares Outstanding	401	401	401	401.44	401.82	401
Working Capital	1,460	1,358	1,520	1,569	1,399	1,895
Book Value Per Share	8.77	8.43	8.35	7.94	7.68	7.43
Tangible Book Value	2,821	2,681	2,628	2,439	2,320	2,959
Tangible Book Value Per Share	7.03	6.69	6.55	6.08	5.77	7.38
Buildings	-	507.12	476.51	274.43	274.43	267.01
Machinery	-	93.04	85.39	73.52	63.46	53.97
Construction In Progress	-	603.06	309.48	253.24	118.62	2.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.